These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34768602)

  • 1. Blood Neurofilament Light Chain in Parkinson's Disease: Comparability between Parkinson's Progression Markers Initiative (PPMI) and Asian Cohorts.
    Chen JH; Chan L; Chung CC; Bamodu OA; Hong CT
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.
    Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK
    Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson's Disease.
    Ma LZ; Zhang C; Wang H; Ma YH; Shen XN; Wang J; Tan L; Dong Q; Yu JT
    J Parkinsons Dis; 2021; 11(3):1117-1127. PubMed ID: 33935105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with
    Sheng ZH; Ma LZ; Liu JY; Ou YN; Zhao B; Ma YH; Tan L
    Front Aging Neurosci; 2022; 14():1061096. PubMed ID: 36589544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson's disease.
    Yang D; Xie H; Wu S; Ying C; Chen Y; Ge Y; Yao R; Li K; Jiang Z; Chen G
    NPJ Parkinsons Dis; 2023 Sep; 9(1):132. PubMed ID: 37699957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease.
    Sampedro F; Pérez-González R; Martínez-Horta S; Marín-Lahoz J; Pagonabarraga J; Kulisevsky J
    Parkinsonism Relat Disord; 2020 May; 74():43-49. PubMed ID: 32334380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofilament light chain level in plasma extracellular vesicles and Parkinson's disease.
    Chung CC; Chan L; Chen JH; Bamodu OA; Hong CT
    Ther Adv Neurol Disord; 2020; 13():1756286420975917. PubMed ID: 33335563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis.
    Hu X; Yang Y; Gong D
    Neurol Sci; 2017 Mar; 38(3):407-414. PubMed ID: 27896490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilament light as a biomarker for motor decline in Parkinson's disease.
    Liu Y; Dou K; Xue L; Li X; Xie A
    Front Neurosci; 2022; 16():959261. PubMed ID: 36117629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson's disease.
    Park DG; Kim JW; An YS; Chang J; Yoon JH
    J Neural Transm (Vienna); 2021 Dec; 128(12):1853-1861. PubMed ID: 34568970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease.
    Lin CW; Lai TT; Chen SJ; Lin CH
    Geroscience; 2022 Jun; 44(3):1551-1562. PubMed ID: 35484471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between plasma NFL and disease progression in Parkinson's disease: a prospective cohort study.
    Ou R; Liu K; Lin J; Yang T; Xiao Y; Wei Q; Hou Y; Li C; Zhang L; Jiang Z; Zhao B; Chen X; Song W; Wu Y; Shang H
    J Neurol; 2024 Apr; 271(4):1837-1843. PubMed ID: 38063869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood neurofilament light chain in Parkinson's disease.
    Buhmann C; Magnus T; Choe CU
    J Neural Transm (Vienna); 2023 Jun; 130(6):755-762. PubMed ID: 37067597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.
    Aamodt WW; Waligorska T; Shen J; Tropea TF; Siderowf A; Weintraub D; Grossman M; Irwin D; Wolk DA; Xie SX; Trojanowski JQ; Shaw LM; Chen-Plotkin AS
    Mov Disord; 2021 Dec; 36(12):2945-2950. PubMed ID: 34480363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma NfL, clinical subtypes and motor progression in Parkinson's disease.
    Pilotto A; Imarisio A; Conforti F; Scalvini A; Masciocchi S; Nocivelli S; Turrone R; Gipponi S; Cottini E; Borroni B; Rizzetti MC; Pizzi M; Bonanni L; Sturchio A; Espay AJ; Zetterberg H; Ashton NJ; Hye A; Padovani A
    Parkinsonism Relat Disord; 2021 Jun; 87():41-47. PubMed ID: 33964785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
    Lin CH; Li CH; Yang KC; Lin FJ; Wu CC; Chieh JJ; Chiu MJ
    Neurology; 2019 Sep; 93(11):e1104-e1111. PubMed ID: 31420461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum NFL discriminates Parkinson disease from essential tremor and reflect motor and cognition severity.
    Huang Y; Huang C; Zhang Q; Shen T; Sun J
    BMC Neurol; 2022 Jan; 22(1):39. PubMed ID: 35086487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.
    Dinov ID; Heavner B; Tang M; Glusman G; Chard K; Darcy M; Madduri R; Pa J; Spino C; Kesselman C; Foster I; Deutsch EW; Price ND; Van Horn JD; Ames J; Clark K; Hood L; Hampstead BM; Dauer W; Toga AW
    PLoS One; 2016; 11(8):e0157077. PubMed ID: 27494614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of serum neurofilament light chains with early symptoms related to Parkinson's disease: A cross-sectional study.
    Wang X; Yang X; He W; Song X; Zhang G; Niu P; Chen T
    J Affect Disord; 2023 Dec; 343():144-152. PubMed ID: 37805158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Neurofilament Light Chain as a Marker of Progression in Parkinson's Disease: Long-Term Observation and Implications of Clinical Subtypes.
    Ygland Rödström E; Mattsson-Carlgren N; Janelidze S; Hansson O; Puschmann A
    J Parkinsons Dis; 2022; 12(2):571-584. PubMed ID: 34806619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.